The 20 Best Uveal Melanoma Doctors in New York, US

Richard Carvajal is an Oncologist in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy.

Alexander Shoushtari is an Oncologist in New York, New York. Dr. Shoushtari has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Metastatic Uveal Melanoma, Melanoma, Melanoma of the Eye, Liver Embolization, and Gastrostomy. Dr. Shoushtari is currently accepting new patients.

Jasmine Francis is an Oncologist in New York, New York. Dr. Francis is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. Her top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Shaheer Khan is an Oncologist in New York, New York. Dr. Khan is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Uveal Melanoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Melanoma.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

David Abramson is an Oncologist in New York, New York. Dr. Abramson is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.

Christopher Barker is a Radiation Oncologist in New York, New York. Dr. Barker is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Melanoma of the Eye, and Liver Embolization. Dr. Barker is currently accepting new patients.

Michael Postow is a Dermatologist in New York, New York. Dr. Postow is rated as an Advanced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Uveal Melanoma, Sinus Cancer, Metastatic Uveal Melanoma, and Liver Embolization.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Mali Barbi is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Barbi is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. Her top areas of expertise are Endometrial Cancer, Melanoma of the Eye, Uveal Melanoma, Breast Cancer, and Hormone Replacement Therapy (HRT).

Jedd Wolchok is an Oncologist in New York, New York. Dr. Wolchok is rated as an Advanced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Neuroendocrine Tumor, Anal Cancer, Liver Embolization, and Bone Marrow Transplant. Dr. Wolchok is currently accepting new patients.

Paul Chapman is an Oncologist in New York, New York. Dr. Chapman is rated as an Advanced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Melanoma of the Eye, and Liver Embolization.

Mark Bluth is a Radiologist in Commack, New York. Dr. Bluth is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), and WT1-Related Wilms Tumor Syndromes.

Kimberly Komatsubara is a primary care provider, practicing in Hematologist in New York, New York. Dr. Komatsubara is rated as an Advanced provider by MediFind in the treatment of Uveal Melanoma. Her top areas of expertise are Uveal Melanoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Lung Cancer.

Ekaterina Semenova is an Ophthalmologist in New York, New York. Dr. Semenova is rated as an Advanced provider by MediFind in the treatment of Uveal Melanoma. Her top areas of expertise are Melanoma of the Eye, Retinoblastoma, Choroid Plexus Carcinoma, Iridectomy, and Corneal Transplant. Dr. Semenova is currently accepting new patients.

Benjamin Izar is an Oncologist in New York, New York. Dr. Izar is rated as an Advanced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Uveal Melanoma, Brain Tumor, and Non-Small Cell Lung Cancer (NSCLC). Dr. Izar is currently accepting new patients.

Mark Dickson is an Oncologist in New York, New York. Dr. Dickson is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Endoscopy. Dr. Dickson is currently accepting new patients.

Anna Pavlick is an Oncologist in New York, New York. Dr. Pavlick is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Bone Tumor. Dr. Pavlick is currently accepting new patients.

Aakriti Shukla MD, MSc is an Associate Professor of Ophthalmology at CUMC and Attending Ophthalmologist at the New York Presbyterian Hospital. Dr. Shukla is a board-certified ophthalmologist and specializes in the medical and surgical management of glaucoma and cataracts. Her surgical expertise includes minimally invasive glaucoma surgery, traditional glaucoma surgery, glaucoma laser surgery, and cataract surgery.Dr. Shukla completed her undergraduate studies as a Trustee and Renaissance Scholar at the University of Southern California. She received her medical degree at Columbia University College of Physicians and Surgeons in New York City, where she was awarded a Doris Duke Clinical Research Fellowship and earned the Edith and Denton McKane Memorial Award for Outstanding Research in Ophthalmology. She completed her training as an ophthalmology resident and served as chief resident at Columbia University's Harkness Eye Institute. She earned a Master of Science degree at Columbia University’s Mailman School of Public Health in Patient-Oriented Research. She pursued further glaucoma subspecialty training at the Wilmer Eye Institute at Johns Hopkins University in Baltimore, MD. Prior to her appointment at Columbia University, she served as glaucoma faculty at the Wills Eye Hospital in Philadelphia, PA.Dr. Shukla has published numerous peer-reviewed articles, book chapters, and has been invited to speak nationally and internationally on her patient care and research. She serves on the editorial boards of Ophthalmology and Ophthalmology Glaucoma. She is continually inspired by her patients and aims to improve their quality of life while treating their glaucoma. Dr. Shukla is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.